Literature DB >> 30472537

Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States.

Sean Esteban McCabe1, Timothy E Wilens2, Carol J Boyd3, Kao-Ping Chua4, Terri Voepel-Lewis5, Ty S Schepis6.   

Abstract

OBJECTIVE: To examine the age-specific risk of past-year substance use disorders (SUDs) associated with use and misuse of prescription opioids, stimulants, sedatives and tranquilizers.
METHODS: The authors analyzed nationally representative data from 114,043 U.S. individuals aged 12 and older in the 2015-2016 National Survey on Drug Use and Health. For each controlled medication class, logistic regression was used to model any past-year SUD as a function of use pattern: no use or misuse, use without misuse, prescription drug misuse (PDM). Among individuals reporting PDM, logistic regression was used to model any past-year SUD as a function of PDM subtype (misuse of someone else's medication only, misuse of one's own medication only, and misuse of one's own and someone else's medication). Analyses were stratified by age group.
RESULTS: Controlled medication use was associated with higher odds of any past-year SUD compared to no use in many age groups and medication classes. Compared to non-use, PDM was associated with higher odds of any past-year SUD across virtually all age groups and medication classes. Compared to misuse of one's own medication only, misuse of both someone else's and one's own medication was associated with higher odds of any past-year SUD for many age groups and medication classes among individuals reporting PDM.
CONCLUSIONS: Clinicians should screen all controlled medication users for PDM and SUDs. Age-specific screening may be required due to heterogeneity in the prevalence and risks of use and misuse of different medications. Determination of PDM subtype can guide interventions to prevent SUDs.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benzodiazepine; Epidemiology; Opioid; Stimulant; Substance use disorder

Mesh:

Year:  2018        PMID: 30472537      PMCID: PMC6434705          DOI: 10.1016/j.addbeh.2018.11.010

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  31 in total

1.  Adolescents' Prescription Stimulant Use and Adult Functional Outcomes: A National Prospective Study.

Authors:  Sean Esteban McCabe; Philip Veliz; Timothy E Wilens; John E Schulenberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-12-25       Impact factor: 8.829

2.  Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002-2003 and 2012-2013 National Survey on Drug Use and Health.

Authors:  Ty S Schepis; Sean Esteban McCabe
Journal:  Addict Behav       Date:  2016-04-22       Impact factor: 3.913

3.  The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States.

Authors:  Wilson M Compton; Deborah Dawson; Sarah Q Duffy; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2010-04       Impact factor: 18.112

Review 4.  Prescription drug abuse: from epidemiology to public policy.

Authors:  R Kathryn McHugh; Suzanne Nielsen; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2014-08-28

5.  Trends in Medical and Nonmedical Use of Prescription Opioids Among US Adolescents: 1976-2015.

Authors:  Sean Esteban McCabe; Brady T West; Phil Veliz; Vita V McCabe; Sarah A Stoddard; Carol J Boyd
Journal:  Pediatrics       Date:  2017-03-20       Impact factor: 7.124

6.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

7.  Nonmedical use of prescription stimulants and depressed mood among college students: frequency and routes of administration.

Authors:  Christian J Teter; Anthony E Falone; James A Cranford; Carol J Boyd; Sean Esteban McCabe
Journal:  J Subst Abuse Treat       Date:  2010-02-04

8.  Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders.

Authors:  Timothy Wilens; Courtney Zulauf; MaryKate Martelon; Nicholas R Morrison; Andrew Simon; Nicholas W Carrellas; Amy Yule; Rayce Anselmo
Journal:  J Clin Psychiatry       Date:  2016-07       Impact factor: 4.384

9.  Youth risk behavior surveillance--United States, 2013.

Authors:  Laura Kann; Steve Kinchen; Shari L Shanklin; Katherine H Flint; Joseph Kawkins; William A Harris; Richard Lowry; Emily O'Malley Olsen; Tim McManus; David Chyen; Lisa Whittle; Eboni Taylor; Zewditu Demissie; Nancy Brener; Jemekia Thornton; John Moore; Stephanie Zaza
Journal:  MMWR Suppl       Date:  2014-06-13

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

View more
  18 in total

1.  Benzodiazepine Treatment and Fracture Risk in Young Persons With Anxiety Disorders.

Authors:  Greta A Bushnell; Tobias Gerhard; Stephen Crystal; Mark Olfson
Journal:  Pediatrics       Date:  2020-06-04       Impact factor: 7.124

2.  Psychosocial functioning among college students who misuse stimulants versus other drugs.

Authors:  Veronica T Cole; Andrea M Hussong
Journal:  Addict Behav       Date:  2020-01-21       Impact factor: 3.913

3.  Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young Adults.

Authors:  Kao-Ping Chua; Chad M Brummett; Rena M Conti; Amy Bohnert
Journal:  JAMA Pediatr       Date:  2020-02-01       Impact factor: 16.193

4.  Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students.

Authors:  Timothy E Wilens; MaryKate Martelon; Amy Yule; Tamar A Kaminski; Colin Burke; Ty S Schepis; Sean E McCabe
Journal:  Am J Addict       Date:  2020-05-20

5.  Race Differences in Opioid Misuse and Adolescent Suicidality.

Authors:  Keith Tsz-Kit Chan; Shangyun Zhou; Christina Marsack-Topolewski
Journal:  Child Adolesc Social Work J       Date:  2020-11-05

6.  Assessment of Changes in Alcohol and Marijuana Abstinence, Co-Use, and Use Disorders Among US Young Adults From 2002 to 2018.

Authors:  Sean Esteban McCabe; Brooke J Arterberry; Kara Dickinson; Rebecca J Evans-Polce; Jason A Ford; Jennie E Ryan; Ty S Schepis
Journal:  JAMA Pediatr       Date:  2021-01-01       Impact factor: 16.193

7.  Consideration of Adolescent Pain in Responses to the Opioid Crisis.

Authors:  Marco Battaglia; Patrick D Quinn; Cornelius B Groenewald
Journal:  JAMA Psychiatry       Date:  2020-07-29       Impact factor: 21.596

8.  Sex differences in US emergency department non-fatal visits for benzodiazepine poisonings in adolescents and young adults.

Authors:  Greta A Bushnell; Mark Olfson; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2021-02-15       Impact factor: 4.492

9.  Associations between insufficient sleep and prescription opioid misuse among high school students in the United States.

Authors:  Cornelius B Groenewald; Jennifer A Rabbitts; See Wan Tham; Emily F Law; Tonya M Palermo
Journal:  J Clin Sleep Med       Date:  2021-11-01       Impact factor: 4.062

Review 10.  Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion.

Authors:  Lorraine I Kelley-Quon; Matthew G Kirkpatrick; Robert L Ricca; Robert Baird; Calista M Harbaugh; Ashley Brady; Paula Garrett; Hale Wills; Jonathan Argo; Karen A Diefenbach; Marion C W Henry; Juan E Sola; Elaa M Mahdi; Adam B Goldin; Shawn D St Peter; Cynthia D Downard; Kenneth S Azarow; Tracy Shields; Eugene Kim
Journal:  JAMA Surg       Date:  2021-01-01       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.